纳米药物重编程肿瘤相关巨噬细胞增强抗癌效果

doi:10.3969/j.issn.1000-8535.2023.04.001

广州医药 ›› 2023, Vol. 54 ›› Issue (4): 1-13.DOI: 10.3969/j.issn.1000-8535.2023.04.001

• 专家综述 • 下一篇

纳米药物重编程肿瘤相关巨噬细胞增强抗癌效果

陈明娃, 王俊侠

华南理工大学附属第二医院,广州市第一人民医院（广州 510180）

收稿日期:2023-02-01 出版日期:2023-04-20 发布日期:2023-05-18
通讯作者: 王俊侠,E-mail：eywangjx@scut.edu.cn
作者简介:王俊侠,博士,特聘副研究员,任职于华南理工大学附属第二医院,主要从事生物医用高分子纳米药物载体的构建及其用于肿瘤治疗的研究工作。近年来,在Advanced Functional Materials,ACS Nano,Biomaterials 等SCI一区期刊发表论文10余篇,其中以（共同）第一作者和通信作者发表IF>10的论文9篇;主持国家自然科学基金项目1项,省部级科研项目1项,市厅级科研项目1项,教育部重点实验室开放课题1项;主持广州市青年科技人才托举工程项目1项;参与国家级项目1项,市厅级项目2项;参与建设广州市重点学科（消化病专科）;担任 Chinese Chemical Letters （中国化学快报）第四届青年编委会委员,《广州医药》第六届编委会委员。
基金资助:
国家自然科学基金青年项目（52103160）; 广东省自然科学基金面上项目（2022A1515010074）; 广州市科协青年科技人才托举工程（QT20220101146）

Recent progress of nanoparticle reprogramming of tumor-associated macrophages（TAMs）to enhance anti-tumor activity

CHEN Mingwa, WANG Junxia

Guangzhou First People's Hospital,the Second Affiliated Hospital,South China University of Technology,Guangzhou 510180,China

Received:2023-02-01 Online:2023-04-20 Published:2023-05-18

摘要/Abstract

摘要： 肿瘤相关巨噬细胞（TAMs）是肿瘤微环境中最丰富的免疫细胞之一,M2-TAMs在肿瘤发生、发展、转移和治疗过程中发挥重要作用,被认为是肿瘤治疗中的重要靶点。已有的研究表明,通过将促肿瘤的M2-TAMs重编程为促炎的M1-TAMs可实现抑制肿瘤生长和转移。本综述在介绍TAMs与肿瘤治疗相关背景的基础上,重点关注纳米药物重编程TAMs增强抗肿瘤的研究进展。本文将从TAMs靶向递送各种活性物质进行重编程TAMs和纳米药物介导的异常肿瘤微环境调节的间接重编程TAMs两种方式,综述近年来基于纳米药物递送系统的调控策略及典型例子。

关键词: 纳米药物, 肿瘤相关巨噬细胞（TAMs）, 肿瘤治疗

Abstract: Tumor associated macrophages（TAMs）is one of the most abundant immune cells in the tumor microenvironment．M2-TAMs play an important role in tumor genesis,progression,metastasis and treatment,and is additionally a very important target in tumor therapy．Previous studies have shown that inhibition of tumor growth and metastasis can be achieved by reprogramming M2-TAMs to M1-TAMs．On the basis,this review focuses on the analysis progress of nano-drug reprogramming TAMs to boost anti-tumor．In this paper,we reviewed two methods of reprogramming TAMs for targeted delivery of various active substances and indirect reprogramming TAMs for abnormal tumor microenvironment regulation mediated by nanomedicine．The regulatory strategies and typical samples of nanomedicine delivery systems in recent years were summarized.

Key words: nanomedicine, tumor associated macrophages（TAMs）, tumor therapy

陈明娃, 王俊侠. 纳米药物重编程肿瘤相关巨噬细胞增强抗癌效果[J]. 广州医药, 2023, 54(4): 1-13.

CHEN Mingwa, WANG Junxia. Recent progress of nanoparticle reprogramming of tumor-associated macrophages（TAMs）to enhance anti-tumor activity[J]. Guangzhou Medical Journal, 2023, 54(4): 1-13.

参考文献

[1] PAGET S.The distribution of secondary growths in cancer of the breast[J].Lancet,1889,133(3421):571-573.
[2] BASLAN T,HICKS J.Unravelling biology and shifting paradigms in cancer with single-cell sequencing[J].Nat Rev Cancer,2017,17(9):557-569.
[3] WYNN T A,CHAWLA A,POLLARD J W.Macrophage biology in development,homeostasis and disease[J].Nature,2013,496(7446):445-455.
[4] QIAN B Z,LI J,ZHANG H,et al.CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis[J].Nature,2011,475(7355):222-225.
[5] SU S,LIU Q,CHEN J,et al.A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis[J].Cancer cell,2014,25(5):605-620.
[6] CHEN Q,ZHANG X H,MASSAGUé J.Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs[J].Cancer cell,2011,20(4):538-549.
[7] QIAN B Z,POLLARD J W.Macrophage diversity enhances tumor progression and metastasis[J].Cell,2010,141(1):39-51.
[8] SYLVESTRE M,CRANE C A,PUN S H.Progress on modulating tumor-associated macrophages with biomaterials[J].Adv Mater,2020,32(13):e1902007.
[9] MURRAY P J,ALLEN J E,BISWAS S K,et al.Macrophage activation and polarization:nomenclature and experimental guidelines[J].Immunity,2014,41(1):14-20.
[10] NGAMBENJAWONG C,GUSTAFSON H H,PUN S H.Progress in tumor-associated macrophage(TAM)-targeted therapeutics[J].Adv Drug Deliv Rev,2017(114):206-221.
[11] NAJAFI M,HASHEMI GORADEL N,FARHOOD B,et al.Macrophage polarity in cancer:A review[J].J Cell Biochem,2019,120(3):2756-2765.
[12] SHI J,KANTOFF P W,WOOSTER R,et al.Cancer nanomedicine:progress,challenges and opportunities[J].Nat Rev Cancer,2017,17(1):20-37.
[13] QIAN Y,QIAO S,DAI Y,et al.Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages[J].ACS Nano,2017,11(9):9536-9549.
[14] PANYAM J,LABHASETWAR V.Biodegradable nanoparticles for drug and gene delivery to cells and tissue[J].Adv Drug Deliv Rev,2003,55(3):329-347.
[15] NG K K,LOVELL J F,ZHENG G.Lipoprotein-inspired nanoparticles for cancer theranostics[J].Acc Chem Res,2011,44(10):1105-1113.
[16] CHEN S,QIN F,WANG M,et al.Nanoparticles targeting tumor-associated macrophages:A novel anti-tumor therapy[J].Nano Research,2022,15(3):2177-2195.
[17] ZHANG H,ZHANG X,REN Y,et al.An in situ microenvironmental nano-regulator to inhibit the proliferation and metastasis of 4T1 tumor[J].Theranostics,2019,9(12):3580-3594.
[18] GAN J,DOU Y,LI Y,et al.Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors[J].Biomaterials,2018(178):95-108.
[19] OVAIS M,GUO M,CHEN C.Tailoring nanomaterials for targeting tumor-associated macrophages[J].Adv Mater,2019,31(19):e1808303.
[20] YE J,YANG Y,DONG W,et al.Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages[J].Int J Nanomedicine,2019(14):3203-3220.
[21] YE J,YANG Y,JIN J,et al.Targeted delivery of chlorogenic acid by mannosylated liposomes to effectively promote the polarization of TAMs for the treatment of glioblastoma[J].Bioactive materials,2020,5(3):694-708.
[22] CHEN B,GAO A,TU B,et al.Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery[J].Biomaterials,2020(255):120187.
[23] WEI B,PAN J,YUAN R,et al.Polarization of tumor-associated macrophages by nanoparticle-loaded escherichia coli combined with immunogenic cell death for cancer immunotherapy[J].Nano Lett,2021,21(10):4231-4240.
[24] ZHANG Y,CHEN Y,LI J,et al.Development of toll-like receptor agonist-loaded nanoparticles as precision immunotherapy for reprogramming tumor-associated macrophages[J].ACS Appl Mater Interfaces,2021,13(21):24442-24452.
[25] WANG H Y,GE J C,ZHANG F Y,et al.Dendrobium officinale polysaccharide promotes M1 polarization of TAMs to inhibit tumor growth by targeting TLR2[J].Carbohydrate Polymers,2022(292):119683.
[26] CHENG N,WATKINS-SCHULZ R,JUNKINS R D,et al.A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer[J].JCI Insight,2018,3(22):e120638.
[27] KANEDA M M,MESSER K S,RALAINIRINA N,et al.PI3Kγ is a molecular switch that controls immune suppression[J].Nature,2016,539(7629):437-442.
[28] DE HENAU O,RAUSCH M,WINKLER D,et al.Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells[J].Nature,2016,539(7629):443-447.
[29] LI K,LU L,XUE C,et al.Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo[J].Nanoscale,2020,12(1):130-144.
[30] LI M,LI M,YANG Y,et al.Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy[J].J Control Release,2020(321):23-35.
[31] SUN J H,LIANG X,CAI M,et al.Protein-crowned micelles for targeted and synergistic tumor-associated macrophage reprogramming to enhance cancer treatment[J].Nano Lett,2022,22(11):4410-4420.
[32] LIN M,YANG Z,YANG Y,et al.CRISPR-based in situ engineering tumor cells to reprogram macrophages for effective cancer immunotherapy[J].Nano Today,2022(42):101359.
[33] CHEN M,MIAO Y, QIAN K,et al.Detachable liposomes combined immunochemotherapy for enhanced triple-negative breast cancer treatment through reprogramming of tumor-associated macrophages[J].Nano Lett,2021,21(14):6031-6041.
[34] JIN H,HE Y,ZHAO P,et al.Targeting lipid metabolism to overcome EMT-associated drug resistance via integrin β3/FAK pathway and tumor-associated macrophage repolarization using legumain-activatable delivery[J].Theranostics,2019,9(1):265-278.
[35] YIN W,YU X,KANG X,et al.Remodeling tumor-associated macrophages and neovascularization overcomes eGFR(T790M)-associated drug resistance by PD-L1 nanobody-mediated codelivery[J].Small,2018,14(47):e1802372.
[36] LIU L,YI H,HE H,et al.Tumor associated macrophage-targeted microRNA delivery with dual-responsive polypeptide nanovectors for anti-cancer therapy[J].Biomaterials,2017(134):166-179.
[37] PARAYATH N N,PARIKH A,AMIJI M M.Repolarization of tumor-associated macrophages in a genetically engineered nonsmall cell lung cancer model by intraperitoneal administration of hyaluronic acid-based nanoparticles encapsulating microrna-125b[J].Nano Lett,2018,18(6):3571-3579.
[38] QIAN H,ZHOU T,FU Y,et al.Self-assembled tetrahedral framework nucleic acid mediates tumor-associated macrophage reprogramming and restores antitumor immunity[J].Molecular therapy Nucleic acids,2022(27):763-773.
[39] ESCRIBESE M M,CASAS M,CORBí A L.Influence of low oxygen tensions on macrophage polarization[J].Immunobiology,2012,217(12):1233-1240.
[40] KELLY B,O'NEILL L A.Metabolic reprogramming in macrophages and dendritic cells in innate immunity[J].Cell research,2015,25(7):771-784.
[41] WANG H,TANG Y,FANG Y,et al.Reprogramming tumor immune microenvironment(time)and metabolism via biomimetic targeting codelivery of shikonin/JQ1[J].Nano Lett,2019,19(5):2935-2944.
[42] ZHANG Y,CHOKSI S,CHEN K,et al.ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages[J].Cell research,2013,23(7):898-914.
[43] COVARRUBIAS A,BYLES V,HORNG T.ROS sets the stage for macrophage differentiation[J].Cell Res,2013,23(8):984-985.
[44] ZANGANEH S,HUTTER G,SPITLER R,et al.Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues[J].Nat Nanotechnol,2016,11(11):986-994.
[45] SHI C,LIU T,GUO Z,et al.Reprogramming tumor-associated macrophages by nanoparticle-based reactive oxygen species photogeneration[J].Nano Lett,2018,18(11):7330-7342.
[46] LIU L,HE H,LIANG R,et al.ROS-Inducing micelles sensitize tumor-associated macrophages to tlr3 stimulation for potent immunotherapy[J].Biomacromolecules,2018,19(6):2146-2155.
[47] BHANDARI V,HOEY C,LIU L Y,et al.Molecular landmarks of tumor hypoxia across cancer types[J].Nature Genetics,2019,51(2):308-318.
[48] CHEN Q,CHEN J,YANG Z,et al.Nanoparticle-enhanced radiotherapy to trigger robust cancer immunotherapy[J].Adv Mater,2019,31(10):e1802228.
[49] ZHANG W,SHI Y,LI H,et al.In situ injectable nano-complexed hydrogel based on chitosan/dextran for combining tumor therapy via hypoxia alleviation and TAMs polarity regulation[J].Carbohydrate Polymers,2022(288):119418.

纳米药物重编程肿瘤相关巨噬细胞增强抗癌效果

Recent progress of nanoparticle reprogramming of tumor-associated macrophages（TAMs）to enhance anti-tumor activity

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 1

编辑推荐

Metrics

本文评价